107 related articles for article (PubMed ID: 30198798)
1. Drug-free macromolecular therapeutics exhibit amplified apoptosis in G2/M phase arrested cells.
Li L; Yang J; Wang J; Kopeček J
J Drug Target; 2019; 27(5-6):566-572. PubMed ID: 30198798
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous crosslinking of CD20 and CD38 receptors by drug-free macromolecular therapeutics enhances B cell apoptosis in vitro and in vivo.
Tommy Gambles M; Li J; Christopher Radford D; Sborov D; Shami P; Yang J; Kopeček J
J Control Release; 2022 Oct; 350():584-599. PubMed ID: 36037975
[TBL] [Abstract][Full Text] [Related]
3. Amplification of CD20 Cross-Linking in Rituximab-Resistant B-Lymphoma Cells Enhances Apoptosis Induction by Drug-Free Macromolecular Therapeutics.
Li L; Yang J; Wang J; Kopeček J
ACS Nano; 2018 Apr; 12(4):3658-3670. PubMed ID: 29595951
[TBL] [Abstract][Full Text] [Related]
4. Crosslinking of CD38 Receptors Triggers Apoptosis of Malignant B Cells.
Gambles MT; Li J; Wang J; Sborov D; Yang J; Kopeček J
Molecules; 2021 Jul; 26(15):. PubMed ID: 34361811
[TBL] [Abstract][Full Text] [Related]
5. Human Serum Albumin-Based Drug-Free Macromolecular Therapeutics: Apoptosis Induction by Coiled-Coil-Mediated Cross-Linking of CD20 Antigens on Lymphoma B Cell Surface.
Zhang L; Fang Y; Li L; Yang J; Radford DC; Kopeček J
Macromol Biosci; 2018 Nov; 18(11):e1800224. PubMed ID: 30259654
[TBL] [Abstract][Full Text] [Related]
6. Drug-free macromolecular therapeutics induce apoptosis in cells isolated from patients with B cell malignancies with enhanced apoptosis induction by pretreatment with gemcitabine.
Wang J; Li L; Yang J; Clair PM; Glenn MJ; Stephens DM; Radford DC; Kosak KM; Deininger MW; Shami PJ; Kopeček J
Nanomedicine; 2019 Feb; 16():217-225. PubMed ID: 30639670
[TBL] [Abstract][Full Text] [Related]
7. Drug-free macromolecular therapeutics: Impact of structure on induction of apoptosis in Raji B cells.
Zhang L; Fang Y; Yang J; Kopeček J
J Control Release; 2017 Oct; 263():139-150. PubMed ID: 28024916
[TBL] [Abstract][Full Text] [Related]
8. Human serum albumin-based drug-free macromolecular therapeutics induce apoptosis in chronic lymphocytic leukemia patient cells by crosslinking of CD20 and/or CD38 receptors.
Li J; Gambles MT; Jones B; Williams JA; Camp NJ; Shami PJ; Yang J; Kopeček J
Drug Deliv Transl Res; 2024 May; ():. PubMed ID: 38802679
[TBL] [Abstract][Full Text] [Related]
9. Biorecognition: A key to drug-free macromolecular therapeutics.
Yang J; Li L; Kopeček J
Biomaterials; 2019 Jan; 190-191():11-23. PubMed ID: 30391799
[TBL] [Abstract][Full Text] [Related]
10. Obinutuzumab-Based Drug-Free Macromolecular Therapeutics Synergizes with Topoisomerase Inhibitors.
Gambles MT; Sborov D; Shami P; Yang J; Kopeček J
Macromol Biosci; 2024 Mar; 24(3):e2300375. PubMed ID: 37838941
[TBL] [Abstract][Full Text] [Related]
11. Drug-Free Macromolecular Therapeutics Induce Apoptosis via Calcium Influx and Mitochondrial Signaling Pathway.
Li L; Yang J; Wang J; Kopeček J
Macromol Biosci; 2018 Jan; 18(1):. PubMed ID: 28805013
[TBL] [Abstract][Full Text] [Related]
12. Exploration and Evaluation of Therapeutic Efficacy of Drug-Free Macromolecular Therapeutics in Collagen-Induced Rheumatoid Arthritis Mouse Model.
Wang J; Li Y; Li L; Yang J; Kopeček J
Macromol Biosci; 2020 May; 20(5):e1900445. PubMed ID: 32196951
[TBL] [Abstract][Full Text] [Related]
13. Cell surface self-assembly of hybrid nanoconjugates via oligonucleotide hybridization induces apoptosis.
Chu TW; Yang J; Zhang R; Sima M; Kopeček J
ACS Nano; 2014 Jan; 8(1):719-30. PubMed ID: 24308267
[TBL] [Abstract][Full Text] [Related]
14. Apoptosis may be either suppressed or enhanced with strategic combinations of antineoplastic drugs or anti-IgM.
Lin CK; Nguyen TT; Morgan TL; Mei RL; Kaptein JS; Kalunta CI; Yen CF; Park E; Zou HY; Lad PM
Exp Cell Res; 1998 Oct; 244(1):1-13. PubMed ID: 9770343
[TBL] [Abstract][Full Text] [Related]
15. CD20-induced B cell death can bypass mitochondria and caspase activation.
van der Kolk LE; Evers LM; Omene C; Lens SM; Lederman S; van Lier RA; van Oers MH; Eldering E
Leukemia; 2002 Sep; 16(9):1735-44. PubMed ID: 12200688
[TBL] [Abstract][Full Text] [Related]
16. A bispecific antibody directly induces lymphoma cell death by simultaneously targeting CD20 and HLA-DR.
Zeng J; Liu R; Wang J; Fang Y
J Cancer Res Clin Oncol; 2015 Nov; 141(11):1899-907. PubMed ID: 25773122
[TBL] [Abstract][Full Text] [Related]
17. Anti-CD20 antibody (IDEC-C2B8, rituximab) enhances efficacy of cytotoxic drugs on neoplastic lymphocytes in vitro: role of cytokines, complement, and caspases.
Chow KU; Sommerlad WD; Boehrer S; Schneider B; Seipelt G; Rummel MJ; Hoelzer D; Mitrou PS; Weidmann E
Haematologica; 2002 Jan; 87(1):33-43. PubMed ID: 11801463
[TBL] [Abstract][Full Text] [Related]
18. [Preclinical study of apoptosis of B-NHL cell lines induced by anti-CD20 monoclonal antibody].
Zhang HY; Chen HT; Guan ZZ; Huang Y; Zhang X; Lin TY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Aug; 17(4):883-7. PubMed ID: 19698222
[TBL] [Abstract][Full Text] [Related]
19. Induction of apoptosis by cross-linking antibodies bound to human B-lymphoma cells: expression of Annexin V binding sites on the antibody cap.
Mattes MJ; Michel RB; Goldenberg DM; Sharkey RM
Cancer Biother Radiopharm; 2009 Apr; 24(2):185-93. PubMed ID: 19409040
[TBL] [Abstract][Full Text] [Related]
20. Type II anti-CD20 mAb-induced lysosome mediated cell death is mediated through a ceramide-dependent pathway.
Ren H; Zhang C; Su L; Bi X; Wang C; Wang L; Wu B
Biochem Biophys Res Commun; 2015 Feb; 457(4):572-7. PubMed ID: 25603047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]